Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Medipharm Labs Corp MEDIF


Primary Symbol: T.LABS

Healthcare Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

Recent & Breaking News (TSX:LABS)

Live Investor Conference & Webinar June 20th

PR Newswire June 14, 2019

Extracts Supply Demand Heightens with Surging Alternative Cannabis Markets

Press Releases June 6, 2019

IIROC Trading Resumption - LABS

Canada NewsWire May 29, 2019

MediPharm Labs Corp. Announces Upsize of Bought Deal Financing to $75 Million

GlobeNewswire May 29, 2019

MediPharm Labs Announces $60 Million Bought Deal Equity Financing

GlobeNewswire May 28, 2019

IIROC Trading Halt - LABS

Canada NewsWire May 28, 2019

UPDATE - New York City Icahn School of Medicine at Mount Sinai and Renowned Global Researcher Dr. Hurd, Select MediPharm Labs to Support 500 Patient Major Clinical Study And "CBD International Consortium" to Develop Treatment of Opioid Addiction

GlobeNewswire May 23, 2019

IIROC Trading Resumption - LABS

Canada NewsWire May 22, 2019

IIROC Trading Halt - LABS

Canada NewsWire May 22, 2019

New York City Ichan School of Medicine at Mount Sinai and Renowned Global Researcher Dr. Hurd, Select MediPharm Labs to Support 500 Patient Major Clinical Study and "CBD International Consortium" to Develop Treatment of Opioid Addiction

GlobeNewswire May 22, 2019

MediPharm Labs Australia Awarded Cannabis Manufacturing Licence From Office of Drug Control - Establishes Asia-Pacific Foothold

GlobeNewswire May 21, 2019

Emerald Health Therapeutics Introduces Unique Premium CBD Oil SYNC 25 to British Columbia Recreational Marketplace

GlobeNewswire May 17, 2019

MediPharm Labs Signs Committed Term Sheet for $20 Million Debt Facility With Schedule 1 Bank

GlobeNewswire May 15, 2019

Cronos Group and MediPharm Labs Enter $30 Million Multi-Year Private Label Cannabis Concentrate Supply Agreement with Potential to Increase to $60 Million

GlobeNewswire May 14, 2019

Cronos Group and MediPharm Labs Enter Cannabis Concentrate Supply Agreement

GlobeNewswire May 14, 2019

MediPharm Labs Announces Q1 2019 Revenue of $22 Million and Adjusted EBITDA of $4.3 Million

GlobeNewswire May 10, 2019

MediPharm Labs Sets Date to Release First Quarter 2019 Financial Results

GlobeNewswire May 8, 2019

Aleafia is an Undeniable Value at Current Levels

Ryan Troup May 3, 2019

MediPharm Labs Announces Upgrade to the OTCQX Best Market in the U.S. Under Symbol "MEDIF"

GlobeNewswire May 2, 2019

OTC Markets Group Welcomes MediPharm Labs Corp. to OTCQX

PR Newswire May 2, 2019